Spots Global Cancer Trial Database for prostate neoplasm
Every month we try and update this database with for prostate neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection | NCT03819751 | Prostate Cancer Prostate Neopla... | MRI-targeted pr... | 50 Years - 75 Years | Universitaire Ziekenhuizen KU Leuven | |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Role of Soy Supplementation in Prostate Cancer Development | NCT00255125 | Prostate Neopla... | Soy Supplement Placebo | 18 Years - | VA Office of Research and Development | |
| MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | NCT05710380 | Prostate Cancer Prostate Adenoc... Prostate Neopla... | Risk Map Decisi... Magnetic Resona... Magnetic Resona... | 18 Years - | University of Chicago | |
| Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion | NCT06315595 | Prostate Neopla... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. | NCT03675529 | Prostate Cancer | High Intensity ... | 18 Years - | Rigshospitalet, Denmark | |
| CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer | NCT01985828 | Prostate Adenoc... | CyberKnife Androgen Depriv... Intensity Modul... | 18 Years - | Advocate Health Care | |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine | |
| Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy | NCT03321149 | Prostate Cancer Prostate Neopla... Cancer Sedentary Lifes... | RiseTx | 18 Years - | University of Illinois at Urbana-Champaign | |
| Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer | NCT03828838 | Prostate Neopla... | Lu-177 PSMA-617 | 18 Years - | Radboud University Medical Center | |
| Prostate Cancer Screening Trial Using Imaging | NCT03702439 | Prostate Neopla... | 50 Years - 69 Years | Imperial College London | ||
| The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. | NCT03675529 | Prostate Cancer | High Intensity ... | 18 Years - | Rigshospitalet, Denmark | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. | NCT04792138 | Prostate Cancer Prostate Neopla... | VERDICT MRI Luminal Index I... | 18 Years - 90 Years | University College, London | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Early and Accurate Detection of Prostate Cancer in General Practice | NCT03431753 | Prostate Cancer Prostate Neopla... Prostate Adenoc... | PSA, STHLM3 and... | 50 Years - 69 Years | University of Aarhus | |
| MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | NCT05710380 | Prostate Cancer Prostate Adenoc... Prostate Neopla... | Risk Map Decisi... Magnetic Resona... Magnetic Resona... | 18 Years - | University of Chicago | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | NCT04045717 | Prostate Adenoc... Prostate Cancer Prostate Neopla... | Hypo-FLAME 2.0 ... | 18 Years - | Universitaire Ziekenhuizen KU Leuven | |
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer | NCT03828838 | Prostate Neopla... | Lu-177 PSMA-617 | 18 Years - | Radboud University Medical Center | |
| Addressing Prostate Cancer Information Disparities With eHealth Technology | NCT02787434 | Prostate Neopla... | Prostate Cancer... | 45 Years - 70 Years | Tufts University | |
| Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy | NCT05137561 | Prostate Cancer Prostate Neopla... | PSMA PET guided... MRI directed TR... | 45 Years - 90 Years | PGIMER | |
| An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | NCT02854436 | Prostatic Neopl... | Niraparib | 18 Years - | Janssen Research & Development, LLC | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| Protein Kinase A in Prostate Cancer Tissue. | NCT05460312 | Prostate Neopla... Inflammation Benign Hyperpla... | prostate biopsy | 50 Years - | Ziv Hospital | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | NCT02225262 | Prostate Cancer Cancer of the P... Prostate Neopla... | CyberKnife Radi... | 21 Years - | Community Cancer Center, Normal, Illinois | |
| 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer | NCT02809690 | Prostate Neopla... | CAT 18F-FMAU Laboratory Biom... Multiparametric... Positron Emissi... Ultrasound | 18 Years - | University of Southern California | |
| Pre-Operative Single Shot Rectus Sheath Block | NCT03458598 | Bladder Neoplas... Prostate Neopla... Pelvic Neoplasm Urologic Neopla... Opioid Use Anesthesia, Loc... Pain, Postopera... | Rectus sheath b... Bilateral rectu... Patient control... Subcutaneous in... | 18 Years - | University of Alberta | |
| Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer | NCT03828838 | Prostate Neopla... | Lu-177 PSMA-617 | 18 Years - | Radboud University Medical Center | |
| Role of Soy Supplementation in Prostate Cancer Development | NCT00255125 | Prostate Neopla... | Soy Supplement Placebo | 18 Years - | VA Office of Research and Development | |
| Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) | NCT01630967 | Prostate Neopla... | Degarelix | 18 Years - | British Columbia Cancer Agency | |
| Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient | NCT05422105 | Prostate Cancer Prostate Neopla... | 18F-PSMA-1007 | 20 Years - 100 Years | Primo Biotechnology Co., Ltd | |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | NCT04075305 | Oncology Breast Cancer Prostate Cancer Gynecologic Can... Brain Tumor Brain Cancer Gynecologic Tum... Prostate Tumor Prostate Neopla... Breast Tumor Radiation Toxic... Quality of Life Rectal Cancer Rectal Tumor Rectal Neoplasm... Lung Cancer Lung Tumor Lung Neoplasm Esophageal Canc... Esophagus Cance... Esophageal Tumo... Esophageal Neop... Esophagus Tumor Esophagus Neopl... Pancreatic Canc... Pancreatic Tumo... Pancreatic Neop... Head and Neck C... Head and Neck N... Head and Neck T... Tumor Neoplasms Bladder Cancer Bladder Neoplas... Liver Cancer Liver Neoplasms Liver Metastase... Oligometastases | Radiation thera... | 18 Years - | UMC Utrecht | |
| Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | NCT03572946 | Prostate Neopla... | Targeted prosta... Standard biopsy | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer | NCT04019327 | Prostate Cancer Prostate Adenoc... Prostate Neopla... Prostate Cancer... Castration-resi... | Talazoparib Temozolomide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | NCT06292897 | Prostate Cancer Prostate Adenoc... Prostate Neopla... Prostatic Neopl... Obesity | observational s... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer | NCT02436122 | Prostate Neopla... Pathology | 20 Years - 80 Years | Seoul National University Hospital | ||
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | NCT06292897 | Prostate Cancer Prostate Adenoc... Prostate Neopla... Prostatic Neopl... Obesity | observational s... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | NCT03572946 | Prostate Neopla... | Targeted prosta... Standard biopsy | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | NCT02380027 | Prostate Neopla... | MRI MRI-targeted bi... TRUS-biopsy | 18 Years - | University College, London | |
| Health Gatherings - For Your Health After Cancer | NCT03344757 | Prostate Neopla... Genital Neoplas... Urogenital Neop... Neoplasm, Prost... Genital Disease... Prostatic Disea... | Cultural CBSM Standard CBSM | 18 Years - | University of Miami | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer | NCT02436122 | Prostate Neopla... Pathology | 20 Years - 80 Years | Seoul National University Hospital | ||
| F-18 Sodium Fluoride in Prostate Cancer | NCT01240551 | Prostate Neopla... | F-18 NaF | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Addressing Prostate Cancer Information Disparities With eHealth Technology | NCT02787434 | Prostate Neopla... | Prostate Cancer... | 45 Years - 70 Years | Tufts University | |
| Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion | NCT06315595 | Prostate Neopla... | Non-Interventio... | 18 Years - | Mayo Clinic | |
| Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence | NCT02485665 | Prostate Neopla... Prostatectomy Surgical Proced... Urinary Inconti... Biofeedback Pelvic Floor Exercise | Extracorporeal ... | 20 Years - 85 Years | Seoul National University Hospital | |
| Role of Soy Supplementation in Prostate Cancer Development | NCT00255125 | Prostate Neopla... | Soy Supplement Placebo | 18 Years - | VA Office of Research and Development | |
| Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy | NCT03321149 | Prostate Cancer Prostate Neopla... Cancer Sedentary Lifes... | RiseTx | 18 Years - | University of Illinois at Urbana-Champaign | |
| Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. | NCT04792138 | Prostate Cancer Prostate Neopla... | VERDICT MRI Luminal Index I... | 18 Years - 90 Years | University College, London | |
| A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia | NCT04376008 | Prostate Neopla... | Standard prosta... Targeted and st... | 18 Years - 80 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | NCT05710380 | Prostate Cancer Prostate Adenoc... Prostate Neopla... | Risk Map Decisi... Magnetic Resona... Magnetic Resona... | 18 Years - | University of Chicago | |
| An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | NCT02854436 | Prostatic Neopl... | Niraparib | 18 Years - | Janssen Research & Development, LLC | |
| Capture of Prostatic Trans-rectal Ultrasound Scans for Research | NCT03321864 | Prostate Cancer Prostate Neopla... | Transrectal ult... | 18 Years - 100 Years | Cambridge University Hospitals NHS Foundation Trust | |
| Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer | NCT02436122 | Prostate Neopla... Pathology | 20 Years - 80 Years | Seoul National University Hospital | ||
| Prostate Cancer Screening Trial Using Imaging | NCT03702439 | Prostate Neopla... | 50 Years - 69 Years | Imperial College London | ||
| COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer | NCT03241537 | Prostate Neopla... | Intensity modul... | 20 Years - | Samsung Medical Center | |
| CyberKnife Dose Escalation Prostate Cancer Trial | NCT03822494 | Prostate Cancer Prostate Adenoc... Prostate Neopla... | CyberKnife SBRT | 18 Years - | Crozer-Keystone Health System | |
| Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy | NCT01446991 | Prostate Cancer | Degarelix Degarelix | 40 Years - 80 Years | British Columbia Cancer Agency | |
| Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | NCT03424850 | Prostate Cancer Prostate Neopla... | HDR brachythera... | 18 Years - | Washington University School of Medicine | |
| Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | NCT03572946 | Prostate Neopla... | Targeted prosta... Standard biopsy | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy | NCT00805883 | Prostate Neopla... | Focal Phothterm... | 40 Years - 80 Years | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
